Recent News

rss

Important Information

from the State Medical Board of Ohio

Maker of Naloxone Issues Voluntary Recall For Some Syringe Systems

The opioid overdose antidote Naloxone has been voluntarily recalled by its maker, Hospira. It was prompted by the potential for the presence of embedded and loose particulate matter on the syringe plunger. The recall affects the hospital/institution level according to the announcement made by the FDA.

 

The affected lots are: 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69). Only the injectable type is affected by this recall.

 

More information can be found on the U.S. Food & Drug Administration’s website: https://www.fda.gov/safety/recalls/ucm609668.htm



Comments are closed.

Showing 0 Comment